Incidence of and risk factors for side effects associated with antibiotic treatment for pneumonia
- 8 August 2025
- journal article
- Published by Elsevier in Journal of Infection and Chemotherapy
- Vol. 31 (9) , 102789
Abstract
No abstract availableKeywords
Funding Information
- Pfizer Japan Inc
- Otsuka Pharmaceutical Co Ltd
- Taisho Pharma Co Ltd
- Bayer Yakuhin Kabushiki Kaisha
- Sumitomo Pharma Co Ltd
This publication has 41 references indexed in Scilit:
- Risk Factors for Recurrence of Clostridioides difficile in Hospitalized PatientsJournal of Infection and Public Health, 2021
- Antibacterial antibiotic-induced drug reaction with eosinophilia and systemic symptoms (DRESS) syndrome: a literature reviewEuropean Journal of Clinical Pharmacology, 2020
- Probiotics for the Prevention and Treatment of Antibiotic-Associated DiarrheaJAMA, 2012
- Risk factors for Clostridium difficile toxin-positive diarrhea: a population-based prospective case–control studyEuropean Journal of Clinical Microbiology & Infectious Diseases, 2012
- Tazobactam/piperacillin for moderate-to-severe pneumonia in patients with risk for aspiration: Comparison with imipenem/cilastatinPulmonary Pharmacology & Therapeutics, 2010
- Phenotypic characterization of idiosyncratic drug‐induced liver injuryHepatology, 2009
- Drug-Induced Liver Injury: An Analysis of 461 Incidences Submitted to the Spanish Registry Over a 10-Year PeriodGastroenterology, 2005
- Role of beta-lactam agents in the treatment of community-acquired pneumoniaEuropean Journal of Clinical Microbiology & Infectious Diseases, 2005
- Causality assessment of adverse reactions to drugs—I. A novel method based on the conclusions of international consensus meetings: Application to drug-induced liver injuriesJournal of Clinical Epidemiology, 1993
- Criteria of drug-induced liver disordersJournal of Hepatology, 1990